N6-Methyladenosine enhances the translation of ENO1 to promote the progression of bladder cancer by inhibiting PCNA ubiquitination
Cancer Letters · 2024-07 · 595 · 217002
DOI: 10.1016/j.canlet.2024.217002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2024-07. Verfasst von Chengquan Shen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Ubiquitination, Tumor Suppressor Proteins, DNA-Binding Proteins. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Taishan Scholar Foundation of Shandong Province, Taishan Scholar Project of Shandong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
The mechanism underlying N6-methyladenosine (m6A) modification in bladder cancer (BC) remains elusive. We identified that the RBM15/METTL3 complex enhances m6A modification and promotes the ENO1 protein translation efficiency through its 359A site by depending on YTHDF1 in BC cells. In the tumor microenvironment, TGF-β effectively stimulates RBM15/METTL3 expression to improve ENO1 mRNA m6A modification through the Smad2/3 pathway. Reduced ENO1 m6A levels hamper tumor proliferation both in vitro and in vivo. Mechanistically, ENO1 augments PCNA protein stability by reducing its K48-linked ubiquitination and thus prevents protein degradation through the endoplasmic reticulum-associated degradation pathway. According to the subsequent experiments, the ENO1 inhibitor significantly reduced tumor proliferation both in vitro and in vivo. Our study highlights the significance of RBM15/METTL3 complex-mediated ENO1 mRNA m6A modification in ENO1 expression. It also reveals a novel mechanism by which ENO1 promotes BC progression, thereby suggesting that ENO1 can be a therapeutic target for BC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
- Department of Research Management and International Cooperation, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
- Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China; Qingdao Clinical Medical Research Center for Urinary System Diseases, Qingdao, Shandong, China; Shandong Province Medical a…
Förderung
- Taishan Scholar Foundation of Shandong Province
- Taishan Scholar Project of Shandong Province
- National Natural Science Foundation of China
Zitieren
APA
Shen, C., Liu, J., Xie, F., Yu, Y., Ma, X., Hu, D., Liu, C., & Wang, Y. (2024). N6-Methyladenosine enhances the translation of ENO1 to promote the progression of bladder cancer by inhibiting PCNA ubiquitination. Cancer Letters, 595, 217002. https://doi.org/10.1016/j.canlet.2024.217002
Vancouver
Shen C, Liu J, Xie F, Yu Y, Ma X, Hu D, et al. N6-Methyladenosine enhances the translation of ENO1 to promote the progression of bladder cancer by inhibiting PCNA ubiquitination. Cancer Letters. 2024;595:217002. doi:10.1016/j.canlet.2024.217002
BibTeX
@article{Shen2024,
author = {Shen, Chengquan and Liu, Jing and Xie, Fei and Yu, Yongbo and Ma, Xiaocheng and Hu, Ding and Liu, Changxue and Wang, Yonghua},
title = {N6-Methyladenosine enhances the translation of ENO1 to promote the progression of bladder cancer by inhibiting PCNA ubiquitination},
journal = {Cancer Letters},
year = {2024},
volume = {595},
pages = {217002},
doi = {10.1016/j.canlet.2024.217002}
}
EUVIMED